Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
HeartBeam reports Q3 2025 results, missing EPS estimates. The pre-revenue firm focuses on FDA clearance for its cardiac tech, a key milestone expected by year-end.
HeartBeam (NASDAQ: BEAT) has cemented its position as a vanguard in medical technology, earning multiple prestigious accolades that underscore its groundbreaking contributions to portable ECG innovation. Most notably, the company was recently identified as a Global IP and Technology Leader in Portable Cardiac Diagnostics by PatentVest's "Total Cardiac Intelligence" report, placing it second worldwide in [...]
HeartBeam Inc. reports Q2 2025 results with a net loss of $5M, beating EPS estimates. FDA clearance for ECG tech expected by year-end amid steady cash burn. Stock shows mixed reaction.
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.
Heartbeam shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The company last week said it secured two new patents.
